The Need for Speed in Biodefense: How JPEO-CBRND is Positioning for Rapid Response CBRNE August 11, 2023 …
A-Alpha Bio and Lawrence Livermore to Accelerate Antibody Discovery and Development for Biothreats Industry News May 16, 2023 …
Protection from Biothreats: DOD to Modernize Medical Countermeasures Development CBRNE January 10, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
JPEO-CBRND Seeks Prototype Proposals for Vaccine Acceleration Program Contracts + Grants November 15, 2021 …
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine Medical Countermeasures October 4, 2021 …
Humanetics’ Radiation Medical Countermeasure Receives FDA Fast Track Designation CBRNE August 24, 2021 …
Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients Contracts + Grants January 30, 2021 …
DoD Awards Funding to Pulmotect to Study Repurposed PUL-042 Against COVID-19 Contracts + Grants January 27, 2021 …
DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal Biodetection October 15, 2020 …
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV Biodetection October 8, 2020 …
National COVID-19 Vaccination Strategy: DoD Awards $125M to Goldbelt Security Health Security September 4, 2020 …
Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures June 8, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Scientists from Noblis and DoD Identify Unique Genetic Sequences of Emerging Coronavirus Threat Pathogens February 13, 2020 …
FDA and DoD Sign Memorandum to Enhance Engagement on Medical Products for Servicemembers Defense + Military December 2, 2018 …
